Refining American Joint Committee on Cancer/Union for International Cancer Control TNM stage and prognostic groups for human papillomavirus-related oropharyngeal carcinomas.
about
HPV Associated Head and Neck CancerAdvanced oropharyngeal squamous cell carcinoma: Pathogenesis, treatment, and novel therapeutic approachesOral cavity and oropharyngeal squamous cell carcinoma--an updateModulation of therapeutic sensitivity by human papillomavirusManagement of Oropharyngeal Cancer in the HPV Era.Clinical features and treatment strategy for HPV-related oropharyngeal cancer.DEK associates with tumor stage and outcome in HPV16 positive oropharyngeal squamous cell carcinoma.Update on De-intensification and Intensification Studies in HPV.Heterogeneity of (18)F-FDG PET combined with expression of EGFR may improve the prognostic stratification of advanced oropharyngeal carcinoma.PATHOS: a phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for Human papillomavirus (HPV) positive oropharyngeal cancer.Establishment of an integrated model incorporating standardised uptake value and N-classification for predicting metastasis in nasopharyngeal carcinomaProposed Staging System for Patients With HPV-Related Oropharyngeal Cancer Based on Nasopharyngeal Cancer N Categories.Systemic inflammation is an independent predictive marker of clinical outcomes in mucosal squamous cell carcinoma of the head and neck in oropharyngeal and non-oropharyngeal patients.Transoral laser microsurgery for oropharyngeal squamous cell carcinoma: A paradigm shift in therapeutic approach.Advice about Work-Related Issues to Peers and Employers from Head and Neck Cancer SurvivorsPopulation-based validation of the recursive partitioning analysis-based staging system for oropharyngeal cancer.A different entity: a population based study of characteristics and recurrence patterns in oropharyngeal squamous cell carcinomas.Genetic Landscape of Human Papillomavirus-Associated Head and Neck Cancer and Comparison to Tobacco-Related Tumors.Smoking cessation care among patients with head and neck cancer: a systematic review.Understanding the impact of survival and human papillomavirus tumor status on timing of recurrence in oropharyngeal squamous cell carcinoma.Relation between the level of lymph node metastasis and survival in locally advanced head and neck squamous cell carcinoma.Serum Antibodies to HPV16 Early Proteins Warrant Investigation as Potential Biomarkers for Risk Stratification and Recurrence of HPV-Associated Oropharyngeal CancerHuman Papillomavirus Infections are Common and Predict Mortality in a Retrospective Cohort Study of Taiwanese Patients With Oral Cavity Cancer.Prognostic Importance of Comorbidity and the Association Between Comorbidity and p16 in Oropharyngeal Squamous Cell Carcinoma.Impact of label-free technologies in head and neck cancer circulating tumour cells.Human Papillomavirus-Associated Oropharyngeal Cancer: Defining Risk Groups and Clinical Trials.Determining optimal follow-up in the management of human papillomavirus-positive oropharyngeal cancer.Clinical outcomes for patients presenting with N3 head and neck squamous cell carcinoma: Analysis of the National Cancer Database.Oropharyngeal cancer and human papilloma virus: evolving diagnostic and management paradigms.Challenges in establishing the diagnosis of human papillomavirus-related oropharyngeal carcinoma.Long-Term, Prospective Performance of the MD Anderson Dysphagia Inventory in "Low-Intermediate Risk" Oropharyngeal Carcinoma After Intensity Modulated Radiation Therapy.MicroRNAs in non-small cell lung cancer invasion and metastasis: from the perspective of the radiation oncologist.Phase I trial of dacomitinib, a pan-human epidermal growth factor receptor (HER) inhibitor, with concurrent radiotherapy and cisplatin in patients with locoregionally advanced squamous cell carcinoma of the head and neck (XDC-001).Strategy of Using Intratreatment Hypoxia Imaging to Selectively and Safely Guide Radiation Dose De-escalation Concurrent With Chemotherapy for Locoregionally Advanced Human Papillomavirus-Related Oropharyngeal CarcinomaOncologic outcomes of selective neck dissection in HPV-related oropharyngeal squamous cell carcinoma.Effect of HPV on head and neck cancer patient survival, by region and tumor site: A comparison of 1362 cases across three continents.Predictors of distant metastasis in human papillomavirus-associated oropharyngeal cancer.Tumor Staging and HPV-Related Oropharyngeal Cancer.Treatment de-intensification strategies for head and neck cancer.Outcomes of surgically treated human papillomavirus-related oropharyngeal squamous cell carcinoma with N3 disease.
P2860
Q26741386-5B935125-D081-4D33-B73E-B1E4EE309A99Q26767046-A39F0A2E-D79D-43BE-B1C7-333B2EBDF941Q26799210-7948571B-09B8-4E8F-858F-E6B849E0492BQ28087031-DC2D8609-CD6F-44E8-B817-B6102E9D8428Q30248326-5D86D956-161D-4A9B-B3C4-695954E46011Q30249150-AA480C60-E519-4402-BBF1-373849E22E48Q33618700-4CD57056-37F6-4E13-A917-B5B758DEBC14Q34541908-E99ECFAE-FE06-4189-952A-769177496C20Q35756750-C2E35F4C-6062-4943-A956-B1C684947E56Q35756867-8ECC9059-0AE1-40CC-AB4D-0DB0C2C9132DQ35921982-8ED8B4BB-24E4-48D9-B5A7-B2C24C882A70Q35925634-CEA30505-424F-4E6A-919A-E66A129B6731Q35927872-95710450-EC37-4A07-AA42-AA349425A6EEQ35978949-8C68229E-BED6-4803-8738-0AE87C2BED24Q35987210-2A38BA14-5B00-4A7C-92D8-7E3D503D846BQ35990622-CE384A5D-D077-4A74-9114-0F9DEB8A0F0FQ36000879-BB62023F-EDD9-4358-B9C1-AE657205249DQ36100833-616E7DF0-F1FB-4F64-8BFB-C2015A215D65Q36138958-AD901AD2-0CFB-4B2B-A97E-09E9510DB4DDQ36405555-FCF41886-3F38-4975-BFA8-859AE21ECB9EQ36547246-6E03DB74-A2B5-409A-9D52-49F910B3B1AAQ36737621-E58FF227-4376-4C7F-934B-0FBC2EE5C106Q37328581-B92FF0B3-B016-40A2-8059-F9C4DD20E7DBQ37376041-08F8AE7C-1465-42E8-BB69-7EB3D5FB90A1Q37687598-47C74BFB-17E7-42DA-BE42-97B74F09B3B8Q38583292-CECF1ECD-CFA2-4740-9C04-AB1397444F2BQ38632754-676EBF6F-1F8E-4456-9190-F1F195474817Q38652852-18CC4EC3-8315-4BD5-A99E-6142F3F61095Q38674531-8A4E24F0-295F-47B5-B851-ED7D810DB664Q38807472-30FCB262-B595-4109-94A4-17310EDF0BBDQ38835143-E35C50E8-E7DD-4F2B-8DEC-43CE34FEA072Q38841996-E68A83C1-4C7C-4AB4-8DAD-99E2EED1FB0EQ38854643-6C228AFB-F89B-4B6F-A21E-84A9D77EEA76Q38924379-248D85D5-251F-4BB1-ACE8-3FA276DAE780Q38955757-09F136F4-430E-4595-B4B9-921FD0F64BA7Q38959371-924FB318-147E-42FD-8BB3-5E5A48507B81Q38966104-9DDC13D2-EF97-4120-A12F-F2B38BDA3614Q38971551-787446C9-842C-4A5D-9C9A-8ECC40D42DD1Q38984523-1CEA0AD1-2BD8-4924-AEB5-55956F4268C0Q39051213-533BF12D-F817-41C2-8853-27C7DF1D6596
P2860
Refining American Joint Committee on Cancer/Union for International Cancer Control TNM stage and prognostic groups for human papillomavirus-related oropharyngeal carcinomas.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Refining American Joint Commit ...... ated oropharyngeal carcinomas.
@ast
Refining American Joint Commit ...... ated oropharyngeal carcinomas.
@en
type
label
Refining American Joint Commit ...... ated oropharyngeal carcinomas.
@ast
Refining American Joint Commit ...... ated oropharyngeal carcinomas.
@en
prefLabel
Refining American Joint Commit ...... ated oropharyngeal carcinomas.
@ast
Refining American Joint Commit ...... ated oropharyngeal carcinomas.
@en
P2093
P50
P356
P1476
Refining American Joint Commit ...... ated oropharyngeal carcinomas.
@en
P2093
Aaron Hansen
Andrew Bayley
Andrew Hope
Ilan Weinreb
Jonathan Irish
Lillian Siu
Patrick Gullane
P304
P356
10.1200/JCO.2014.58.6412
P407
P50
P577
2015-02-09T00:00:00Z